However, in this study, there was no significant correlation between TP53 co-mutations and PFS and OS, similar to the findings of other prospective and retrospective studies in patients with EGFR-mutated lung cancer [29,30,31,32]. The gene discussed is TP53; the disease is lung carcinoma.